Show simple item record

dc.contributor.authorD’Auria, David
dc.contributor.authorZito Marinosci, Geremia
dc.contributor.authorDe Benedictis, Giuseppe
dc.contributor.authorPiazza, Ornella
dc.date.accessioned2013-04-10T11:15:28Z
dc.date.available2013-04-10T11:15:28Z
dc.date.issued2012
dc.identifier.citationD'Auria D, Zito Marinosci G, De Benedictis G, Piazza O. Vaptans and hyponatremia in critical patients. Translational Medicine @ UniSa 2012;3(1):1-14en_US
dc.identifier.issn2239-9747en_US
dc.identifier.urihttp://hdl.handle.net/10556/536
dc.description.abstractHyponatremia is the most frequent fluid and electrolyte disorder in hospitalized patients (20%), particularly in ICU, associated with an increase in morbility and mortality. While hypovolaemic hyponatremia needs to be corrected with the replacement of the lost extracellular fluid by isotonic saline, euvolaemic (SIADH) and hypervolaemic hyponatremia (oedematous states like decompensated heart failure, liver cirrhosis, i.e.) are treated by restriction of fluid intake, loop diuretics and hypertonic saline. A novel approach consists in use of vaptans, non-peptide arginine vasopressin (AVP) receptor antagonists. Vaptans cause “aquaresis”, which results in the correction of plasma osmolality and serum sodium levels, without activation of the renin-angiotensin-aldosterone system or changes in blood pressure and renal function. In this paper we critically reviewed the results of the available randomized controlled critical trials, discussing the effectiveness and safety of vaptans in treating hypervolaemic and euvolaemic hyponatremia in critical patients.en_US
dc.format.extentP. 1-14en_US
dc.language.isoenen_US
dc.sourceUniSa. Sistema Bibliotecario di Ateneoen_US
dc.subjectAVP receptor antagonistsen_US
dc.subjectHyponatremiaen_US
dc.subjectVaptansen_US
dc.subjectVasopressinen_US
dc.titleVaptans and hyponatremia in critical patientsen_US
dc.typeArticleen_US
 Find Full text

Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record